vesatolimod
Showing 1 - 6 of 6
HIV-1-infection Trial in Umlazi (Vesatolimod, VRC07523LS, CAP256V2LS)
Recruiting
- HIV-1-infection
- Vesatolimod
- +2 more
-
Umlazi, South AfricaFRESH Clinical Research Site: Females Rising through Education,
Jan 4, 2023
Human Immunodeficiency Virus Type 1 (HIV-1) Infection Trial (Vesatolimod, Cobicistat, Voriconazole)
Not yet recruiting
- Human Immunodeficiency Virus Type 1 (HIV-1) Infection
- Vesatolimod
- +3 more
- (no location specified)
Jul 11, 2022
HIV-1 Infection Trial in United States (Vesatolimod, Placebo, ART)
Completed
- HIV-1 Infection
- Vesatolimod
- +2 more
-
Los Angeles, California
- +5 more
Mar 29, 2021
Chronic Hepatitis B Trial in Worldwide (Vesatolimod, Placebo)
Completed
- Chronic Hepatitis B
- Vesatolimod
- Placebo
-
Los Angeles, California
- +22 more
Sep 22, 2020
HIV-1 Infection Trial in United States (Vesatolimod, Placebo, ARV regimen)
Completed
- HIV-1 Infection
- Vesatolimod
- +2 more
-
Los Angeles, California
- +7 more
Feb 7, 2020